Differential involvement of trigeminal transition zone and laminated subnucleus caudalis in orofacial deep and cutaneous hyperalgesia: The effects of interleukin-10 and glial inhibitors

Molecular Pain

Volumn 5, Issue , 2009, Pages

  Shimizu, Kohei ^a,b   Guo, Wei ^a,b   Wang, Hu ^a,b   Zou, Shiping ^a,b   LaGraize, Stacey C ^a,b   Iwata, Koichi ^c   Wei, Feng ^a,b   Dubner, Ronald ^a,b   Ren, Ke ^a,b  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AUTACOID; BIOLOGICAL MARKER; CITRIC ACID; FLUOROCITRIC ACID; FREUND ADJUVANT; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 10; MINOCYCLINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NR1 NMDA RECEPTOR;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; FACE PAIN; GLIA; GLIOSIS; HYPERALGESIA; INNERVATION; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MASSETER MUSCLE; METABOLISM; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TRIGEMINAL NUCLEUS; UPREGULATION;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; CITRATES; DISEASE MODELS, ANIMAL; FACIAL PAIN; FREUND'S ADJUVANT; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; HYPERALGESIA; INFLAMMATION MEDIATORS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-10; MALE; MASSETER MUSCLE; MINOCYCLINE; NEUROGLIA; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; TRIGEMINAL CAUDAL NUCLEUS; UP-REGULATION;

EID: 77649291914     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-5-75     Document Type: Article

References (86)

1. Olszewski J. On the anatomical and functional organization of the spinal trigeminal nucleus. J Comp Neurol 1950, 92:401-413. 10.1002/cne.900920305, 15422069.
2. Sessle BJ. Acute and chronic craniofacial pain: brainstem mechanisms of nociceptive transmission and neuroplasticity, and their clinical correlates. Crit Rev Oral Biol Med 2000, 11:57-91. 10.1177/10454411000110010401, 10682901.
3. Gobel S, Hockfield S, Ruda MA. Anatomical similarities between medullary and spinal dorsal horns. In Oral-Facial Sensory and Motor Functions 1981, 211-223. Tokyo: Quintessence, Kawamura Y, Dubner R.
4. Bereiter DA, Hirata H, Hu JW. Trigeminal subnucleus caudalis: beyond homologies with the spinal dorsal horn. Pain 2000, 88:221-224. 10.1016/S0304-3959(00)00434-6, 11068108.
5. Dubner R, Ren K. Brainstem mechanisms of persistent pain following injury. J Orofac Pain 2004, 18:299-305.
6. Ren K, Dubner R. Central Nervous System Plasticity and Persistent Pain. J Orofacial Pain 1999, 13:155-163.
7. Wang H, Wei F, Dubner R, Ren K. Selective distribution and function of primary afferent nociceptive inputs from deep muscle tissue to the brainstem trigeminal transition zone. J Comp Neurol 2006, 498:390-402. 10.1002/cne.21062, 16871539.
8. Strassman AM, Vos BP. Somatotopic and laminar organization of fos-like immunoreactivity in the medullary and upper cervical dorsal horn induced by noxious facial stimulation in the rat. J Comp Neurol 1993, 331:495-516. 10.1002/cne.903310406, 8509507.
9. Hathaway CB, Hu JW, Bereiter DA. Distribution of Fos-like immunoreactivity in the caudal brainstem of the rat following noxious chemical stimulation of the temporomandibular joint. J Comp Neurol 1995, 356:444-456. 10.1002/cne.903560311, 7642805.
10. Zhou Q, Imbe H, Dubner R, Ren K. Persistent Fos protein expression after orofacial deep or cutaneous tissue inflammation in rats: implications for persistent orofacial pain. J Comp Neurol 1999, 412:276-291. 10.1002/(SICI)1096-9861(19990920)412:2<276::AID-CNE7>3.0.CO;2-9, 10441756.
11. Imbe H, Dubner R, Ren K. Masseteric inflammation-induced Fos protein expression in the trigeminal interpolaris/caudalis transition zone: contribution of somatosensory-vagal-adrenal integration. Brain Res 1999, 845:165-175. 10.1016/S0006-8993(99)01913-7, 10536195.
12. Chattipakorn SC, Sigurdsson A, Light AR, Narhi M, Maixner W. Trigeminal c-Fos expression and behavioral responses to pulpal inflammation in ferrets. Pain 2002, 99:61-69. 10.1016/S0304-3959(02)00054-4, 12237184.
13. Ro JY, Harriott A, Crouse U, Capra NF. Innocuous jaw movements increase c-fos expression in trigeminal sensory nuclei produced by masseter muscle inflammation. Pain 2003, 104:539-548. 10.1016/S0304-3959(03)00093-9, 12927626.
14. Sugiyo S, Takemura M, Dubner R, Ren K. Trigeminal transition zone/rostral ventromedial medulla connections and facilitation of orofacial hyperalgesia after masseter inflammation in rats. J Comp Neurol 2005, 493:510-523. 10.1002/cne.20797, 16304628.
15. Marchand F, Perretti M, McMahon SB. Role of the immune system in chronic pain. Nat Rev Neurosci 2005, 6:521-532. 10.1038/nrn1700, 15995723.
16. Watkins LR, Maier SF. Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med 2005, 257:139-155. 10.1111/j.1365-2796.2004.01443.x, 15656873.
17. Guo W, Wang H, Watanabe M, Shimizu K, Zou S, LaGraize SC, Wei F, Dubner R, Ren K. Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci 2007, 27:6006-6018. 10.1523/JNEUROSCI.0176-07.2007, 2676443, 17537972.
18. Ren K, Dubner R. Neuron-glia crosstalk gets serious: role in pain hypersensitivity. Curr Opin Anaesthesiol 2008, 21:570-9. 10.1097/ACO.0b013e32830edbdf, 2735048, 18784481.
19. Wei F, Guo W, Zou S, Ren K, Dubner R. Supraspinal glial-neuronal interactions contribute to descending pain facilitation. J Neurosci 2008, 28:10482-95. 10.1523/JNEUROSCI.3593-08.2008, 2660868, 18923025.
20. Okada-Ogawa A, Suzuki I, Sessle BJ, Chiang CY, Salter MW, Dostrovsky JO, Tsuboi Y, Kondo M, Kitagawa J, Kobayashi A, Noma N, Imamura Y, Iwata K. Astroglia in medullary dorsal horn (trigeminal spinal subnucleus caudalis) are involved in trigeminal neuropathic pain mechanisms. J Neurosci 2009, 29:11161-11171. 10.1523/JNEUROSCI.3365-09.2009, 2804401, 19741123.
21. Ridet JL, Rajaofetra N, Teilhac JR, Geffard M, Privat A. Evidence for nonsynaptic serotonergic and noradrenergic innervation of the rat dorsal horn and possible involvement of neuron-glia interactions. Neuroscience 1993, 52:143-157. 10.1016/0306-4522(93)90189-M, 8381923.
22. Watkins LR, Milligan EF, Maier SF. Glial activation: a driving force for pathological pain. Trends Neurosci 2001, 24:450-455. 10.1016/S0166-2236(00)01854-3, 11476884.
23. Tsuda M, Inoue K, Salter MW. Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci 2005, 28:101-107. 10.1016/j.tins.2004.12.002, 15667933.
24. Garrison CJ, Dougherty PM, Kajander KC, Carlton SM. Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res 1991, 565:1-7. 10.1016/0006-8993(91)91729-K, 1723019.
25. Garrison CJ, Dougherty PM, Carlton SM. GFAP expression in lumbar spinal cord of naive and neuropathic rats treated with MK-801. Exp Neurol 1994, 129:237-243. 10.1006/exnr.1994.1165, 7957738.
26. Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, Kohsaka S, Salter MW, Inoue K. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 2003, 424:778-783. 10.1038/nature01786, 12917686.
27. Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW, De Koninck Y. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005, 438:1017-1021. 10.1038/nature04223, 16355225.
28. Hains BC, Waxman SG. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J Neurosci 2006, 26:4308-4317. 10.1523/JNEUROSCI.0003-06.2006, 16624951.
29. Zhuang ZY, Wen YR, Zhang DR, Borsello T, Bonny C, Strichartz GR, Decosterd I, Ji RR. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J Neurosci 2006, 26:3551-3560. 10.1523/JNEUROSCI.5290-05.2006, 16571763.
30. Meller ST, Dykstra C, Grzybycki D, Murphy S, Gebhart GF. The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacology 1994, 33:1471-1478. 10.1016/0028-3908(94)90051-5, 7532831.
31. Reeve AJ, Patel S, Fox A, Walker K, Urban L. Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur J Pain 2000, 4:247-257. 10.1053/eujp.2000.0177, 10985868.
32. Falchi M, Ferrara F, Gharib C, Dib B. Hyperalgesic effect of intrathecally administered interleukin-1 in rats. Drugs Exp Clin Res 2001, 27:97-101.
33. Sung CS, Wen ZH, Chang WK, Chan KH, Ho ST, Tsai SK, Chang YC, Wong CS. Inhibition of p38 mitogen-activated protein kinase attenuates interleukin-1beta-induced thermal hyperalgesia and inducible nitric oxide synthase expression in the spinal cord. J Neurochem 2005, 94:742-752. 10.1111/j.1471-4159.2005.03226.x, 16033422.
34. Kanaan SA, Poole S, Saade NE, Jabbur S, Safieh-Garabedian B. Interleukin-10 reduces the endotoxin-induced hyperalgesia in mice. J Neuroimmunol 1998, 86:142-150. 10.1016/S0165-5728(98)00027-7, 9663559.
35. Saade NE, Nasr IW, Massaad CA, Safieh-Garabedian B, Jabbur SJ, Kanaan SA. Modulation of ultraviolet-induced hyperalgesia and cytokine upregulation by interleukins 10 and 13. Br J Pharmacol 2000, 131:1317-1324. 10.1038/sj.bjp.0703699, 1572458, 11090103.
36. Johnston IN, Milligan EF, Wieseler-Frank J, Frank MG, Zapata V, Campisi J, Langer S, Martin D, Green P, Fleshner M, Leinwand L, Maier SF, Watkins LR. A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J Neurosci 2004, 24:7353-7365. 10.1523/JNEUROSCI.1850-04.2004, 15317861.
37. Laughlin TM, Bethea JR, Yezierski RP, Wilcox GL. Cytokine involvement in dynorphin-induced allodynia. Pain 2000, 84:159-167. 10.1016/S0304-3959(99)00195-5, 10666520.
38. Ikeda T, Terayama R, Jue SS, Sugiyo S, Dubner R, Ren K. Differential rostral projections of caudal brainstem neurons receiving trigeminal input after masseter inflammation. J Comp Neurol 2003, 465:220-233. 10.1002/cne.10836, 12949783.
39. Watanabe M, Guo W, Zou S, Sugiyo S, Dubner R, Ren K. Antibody array analysis of peripheral and blood cytokine levels in rats after masseter inflammation. Neurosci Lett 2005, 382:128-133. 10.1016/j.neulet.2005.03.002, 15911135.
40. Ren K. An improved method for assessing mechanical allodynia in the rat. Physiol Behav 1999, 67:711-716. 10.1016/S0031-9384(99)00136-5, 10604842.
41. Guo W, Wei F, Zou S, Robbins MT, Sugiyo S, Ikeda T, Tu JC, Worley PF, Dubner R, Ren K. Group I metabotropic glutamate receptor NMDA receptor coupling and signaling cascade mediate spinal dorsal horn NMDA receptor 2B tyrosine phosphorylation associated with inflammatory hyperalgesia. J Neurosci 2004, 24:9161-9173. 10.1523/JNEUROSCI.3422-04.2004, 15483135.
42. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 2005, Amsterdam: Elsevier, Fifth.
43. MacArthur L, Ren K, Pfaffenroth E, Franklin E, Ruda MA. Descending modulation of opioid-containing nociceptive neurons in rats with peripheral inflammation and hyperalgesia. Neuroscience 1999, 88:499-506. 10.1016/S0306-4522(98)00204-8, 10197770.
44. Imbe H, Ren K. Orofacial deep and cutaneous tissue inflammation differentially upregulates preprodynorphin mRNA in the trigeminal and paratrigeminal nuclei of the rat. Brain Res Mol Brain Res 1999, 67:87-97. 10.1016/S0169-328X(99)00040-6, 10101236.
45. Wong H, Anderson WD, Cheng T, Riabowol KT. Monitoring mRNA expression by polymerase chain reaction: the "primer-dropping" method. Anal Biochem 1994, 223:251-258. 10.1006/abio.1994.1581, 7887471.
46. Reid KI, Carlson C, Rayens MK, Gracely RH. The influence of cutaneous tissue afferents on masticatory pain-pressure thresholds. J Orofac Pain 1996, 10:324-329.
47. Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 2001, 21:2580-2588.
48. Raghavendra V, Tanga F, DeLeo JA. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 2003, 306:624-630. 10.1124/jpet.103.052407, 12734393.
49. Reimers J, Wogensen LD, Welinder B, Hejnaes KR, Poulsen SS, Nilsson P, Nerup J. The pharmacokinetics, distribution and degradation of human recombinant interleukin 1 beta in normal rats. Scand J Immunol 1991, 34:597-610. 10.1111/j.1365-3083.1991.tb01583.x, 1947795.
50. Zou X, Lin Q, Willis WD. Enhanced phosphorylation of NMDA receptor 1 subunits in spinal cord dorsal horn and spinothalamic tract neurons after intradermal injection of capsaicin in rats. J Neurosci 2000, 20:6989-6997.
51. Guo W, Zou S-P, Guan Y, Ikeda T, Tal M, Dubner R, Ren K. Tyrosine phosphorylation of the NR2B subunit of the NMDA receptor in the spinal cord during the development and maintenance of inflammatory hyperalgesia. J Neurosci 2002, 22:6208-6217.
52. Brenner GJ, Ji RR, Shaffer S, Woolf CJ. Peripheral noxious stimulation induces phosphorylation of the NMDA receptor NR1 subunit at the PKC-dependent site, serine-896, in spinal cord dorsal horn neurons. Eur J Neurosci 2004, 20:375-384. 10.1111/j.1460-9568.2004.03506.x, 15233747.
53. Roitt I, Rabson A. Really essential medical immunology. 2000, Oxford: Blackwell Science.
54. Strle K, Zhou JH, Shen WH, Broussard SR, Johnson RW, Freund GG, Dantzer R, Kelley KW. Interleukin-10 in the brain. Crit Rev Immunol 2001, 21:427-449.
55. Kennedy MK, Torrance DS, Picha K, Mohler KM. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 1992, 149:2496-2505.
56. Haddad JJ, Saade NE, Safieh-Garabedian B. Interleukin-10 and the regulation of mitogen-activated protein kinases: are these signalling modules targets for the anti-inflammatory action of this cytokine?. Cell Signal 2003, 15:255-267. 10.1016/S0898-6568(02)00075-X, 12531424.
57. Zhang RX, Li A, Liu B, Wang L, Ren K, Zhang H, Berman BM, Lao L. IL-1ra alleviates inflammatory hyperalgesia through preventing phosphorylation of NMDA receptor NR-1 subunit in rats. Pain 2008, 135:232-239. 10.1016/j.pain.2007.05.023, 2323207, 17689191.
58. Abraham KE, McMillen D, Brewer KL. The effects of endogenous interleukin-10 on gray matter damage and the development of pain behaviors following excitotoxic spinal cord injury in the mouse. Neuroscience 2004, 124:945-952. 10.1016/j.neuroscience.2004.01.004, 15026134.
59. Milligan EF, Langer SJ, Sloane EM, He L, Wieseler-Frank J, O'Connor K, Martin D, Forsayeth JR, Maier SF, Johnson K, Chavez RA, Leinwand LA, Watkins LR. Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. Eur J Neurosci 2005, 21:2136-2148. 10.1111/j.1460-9568.2005.04057.x, 15869510.
60. Ledeboer A, Jekich BM, Sloane EM, Mahoney JH, Langer SJ, Milligan EF, Martin D, Maier SF, Johnson KW, Leinwand LA, Chavez RA, Watkins LR. Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats. Brain Behav Immun 2007, 21:686-698. 10.1016/j.bbi.2006.10.012, 2063454, 17174526.
61. Watkins LR, Martin D, Ulrich P, Tracey KJ, Maier SF. Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain 1997, 71:225-235. 10.1016/S0304-3959(97)03369-1, 9231865.
62. Ledeboer A, Sloane EM, Milligan EF, Frank MG, Mahony JH, Maier SF, Watkins LR. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 2005, 115:71-83. 10.1016/j.pain.2005.02.009, 15836971.
63. Clark AK, Gentry C, Bradbury EJ, McMahon SB, Malcangio M. Role of spinal microglia in rat models of peripheral nerve injury and inflammation. Eur J Pain 2007, 11:223-230. 10.1016/j.ejpain.2006.02.003, 16545974.
64. Hosoi R, Okada M, Hatazawa J, Gee A, Inoue O. Effect of astrocytic energy metabolism depressant on 14C-acetate uptake in intact rat brain. J Cereb Blood Flow Metab 2004, 24:188-190. 10.1097/01.WCB.0000098606.42140.02, 14747745.
65. Verkhratsky A, Kettenmann H. Calcium signalling in glial cells. Trends Neurosci 1996, 19:346-352. 10.1016/0166-2236(96)10048-5, 8843604.
66. Araque A, Parpura V, Sanzgiri RP, Haydon PG. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 1999, 22:208-215. 10.1016/S0166-2236(98)01349-6, 10322493.
67. Frerking M. When astrocytes signal, kainate receptors respond. Proc Natl Acad Sci USA 2004, 101:2649-2650. 10.1073/pnas.0400474101, 365674, 14981250.
68. Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, Von Zastrow M, Beattie MS, Malenka RC. Control of synaptic strength by glial TNFalpha. Science 2002, 295:2282-2285. 10.1126/science.1067859, 11910117.
69. Stellwagen D, Malenka RC. Synaptic scaling mediated by glial TNF-alpha. Nature 2006, 440:1054-1059. 10.1038/nature04671, 16547515.
70. Sung B, Lim G, Mao J. Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J Neurosci 2003, 23:2899-2910.
71. Liaw WJ, Stephens RL, Binns BC, Chu Y, Sepkuty JP, Johns RA, Rothstein JD, Tao YX. Spinal glutamate uptake is critical for maintaining normal sensory transmission in rat spinal cord. Pain 2005, 115:60-70. 10.1016/j.pain.2005.02.006, 15836970.
72. Weng HR, Aravindan N, Cata JP, Chen JH, Shaw AD, Dougherty PM. Spinal glial glutamate transporters downregulate in rats with taxol-induced hyperalgesia. Neurosci Lett 2005, 386:18-22. 10.1016/j.neulet.2005.05.049, 15975716.
73. Weng HR, Chen JH, Cata JP. Inhibition of glutamate uptake in the spinal cord induces hyperalgesia and increased responses of spinal dorsal horn neurons to peripheral afferent stimulation. Neuroscience 2006, 138:1351-1360. 10.1016/j.neuroscience.2005.11.061, 16426766.
74. Sweitzer S, Martin D, DeLeo JA. Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience 2001, 103:529-539. 10.1016/S0306-4522(00)00574-1, 11246166.
75. Tawfik VL, Lacroix-Fralish ML, Bercury KK, Nutile-McMenemy N, Harris BT, Deleo JA. Induction of astrocyte differentiation by propentofylline increases glutamate transporter expression in vitro: heterogeneity of the quiescent phenotype. Glia 2006, 54:193-203. 10.1002/glia.20365, 16819765.
76. Clark AK, D'Aquisto F, Gentry C, Marchand F, McMahon SB, Malcangio M. Rapid co-release of interleukin 1beta and caspase 1 in spinal cord inflammation. J Neurochem 2006, 99:868-880. 10.1111/j.1471-4159.2006.04126.x, 16942597.
77. Tanga FY, Nutile-McMenemy N, DeLeo JA. The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci USA 2005, 102:5856-5861. 10.1073/pnas.0501634102, 556308, 15809417.
78. Kawasaki Y, Xu ZZ, Wang X, Park JY, Zhuang ZY, Tan PH, Gao YJ, Roy K, Corfas G, Lo EH, Ji RR. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 2008, 14:331-336. 10.1038/nm1723, 2279180, 18264108.
79. Miyoshi K, Obata K, Kondo T, Okamura H, Noguchi K. Interleukin-18-mediated microglia/astrocyte interaction in the spinal cord enhances neuropathic pain processing after nerve injury. J Neurosci 2008, 28:12775-12787. 10.1523/JNEUROSCI.3512-08.2008, 19036970.
80. Balasingam V, Yong VW. Attenuation of astroglial reactivity by interleukin-10. J Neurosci 1996, 16:2945-2955.
81. Rajasingh J, Bord E, Luedemann C, Asai J, Hamada H, Thorne T, Qin G, Goukassian D, Zhu Y, Losordo DW, Kishore R. IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression. FASEB J 2006, 20:2112-2124. 10.1096/fj.06-6084fje, 16935932.
82. Dubner R, Ren K. Persistent Orofacial Pain. Temporomandibular Disorders: An Evidence-Based Approach to Diagnosis and Treatment 2006, 89-97. Chicago: Quintessence Publishing Co, Inc, Laskin DM, Greene CS, Hylander WL.
83. Ren K, Dubner R. Descending modulation in persistent pain: An update. Pain 2002, 100:1-6. 10.1016/S0304-3959(02)00368-8, 12435453.
84. Meng ID, Hu JW, Bereiter DA. Differential effects of morphine on corneal-responsive neurons in rostral versus caudal regions of spinal trigeminal nucleus in the rat. J Neurophysiol 1998, 79:2593-2602.
85. Bereiter DA, Shen S, Benetti AP. Sex differences in amino acid release from rostral trigeminal subnucleus caudalis after acute injury to the TMJ region. Pain 2002, 98:89-99. 10.1016/S0304-3959(01)00476-6, 12098620.
86. Hirata H, Okamoto K, Bereiter DA. GABA(A) receptor activation modulates corneal unit activity in rostral and caudal portions of trigeminal subnucleus caudalis. J Neurophysiol 2003, 90:2837-2849. 10.1152/jn.00544.2003, 12890797.